about
Nonhuman primate models of Alzheimer-like cerebral proteopathyNeuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer diseaseVector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex.Amyloid-beta peptide and oligomers in the brain and cerebrospinal fluid of aged canines.Cerebral amyloid β(42) deposits and microvascular pathology in ageing baboons.CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer's disease mouse models.Beyond counts and shapes: studying pathology of dendritic spines in the context of the surrounding neuropil through serial section electron microscopy.Alzheimer's disease abeta vaccine reduces central nervous system abeta levels in a non-human primate, the Caribbean vervet.CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model.Amyloidosis in aging and Alzheimer's diseaseMicroinjection of synthetic amyloid beta-protein in monkey cerebral cortex fails to produce acute neurotoxicityDistribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex.Cyclic intensive light exposure induces retinal lesions similar to age-related macular degeneration in APPswe/PS1 bigenic miceDownregulation of amyloid precursor protein inhibits neurite outgrowth in vitro.Alzheimer disease and the prion disorders amyloid beta-protein and prion protein amyloidoses.Amyloid precursor protein (APP) and beta A4 amyloid in the etiology of Alzheimer's disease: precursor-product relationships in the derangement of neuronal function.Aged non-human primates: an animal model of age-associated neurodegenerative disease.Transgenic models of Alzheimer's disease: better utilization of existing models through viral transgenesis.Beta-amyloid precursor protein cleavage by a membrane-bound protease.Drug targeting of a peptide radiopharmaceutical through the primate blood-brain barrier in vivo with a monoclonal antibody to the human insulin receptorNSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease.Alzheimer's disease and the amyloid-beta peptide.Modelling early responses to neurodegenerative mutations in mice.Recent rodent models for Alzheimer's disease: clinical implications and basic research.Review: Axon pathology in age-related neurodegenerative disorders.Is sporadic Alzheimer's disease a developmental disorder?Enforced DNA repair enzymes rescue neurons from apoptosis induced by target deprivation and axotomy in mouse models of neurodegeneration.Beta-amyloid precursor protein isoforms in various rat brain regions and during brain development.Amyloid precursor protein and ubiquitin immunoreactivity in dystrophic axons is not unique to Alzheimer's disease.Alzheimer's disease. Beta-amyloid precursor protein expression in the nucleus basalis of Meynert.Alzheimer's disease pathology in the neocortex and hippocampus of the western lowland gorilla (Gorilla gorilla gorilla).Immunohistochemical characteristics of the constituents of senile plaques and amyloid angiopathy in aged cynomolgus monkeys.The treatment of Alzheimer's diseaseImmunohistochemical detection of β-amyloid and β-amyloid precursor protein in the canine brain and non-neuronal epithelial tissues
P2860
Q28728135-BD102E35-EB19-42D2-973E-4EC90BABE76DQ28775941-F7DD6AD5-630E-47AC-BFA2-F7C9E2F2BA70Q33827984-9618A971-90C2-4DE5-9DEF-964198A0BAD7Q33993315-D4B0CD99-9778-4197-AFA8-6504F2F13A75Q34086022-2B6F024E-A725-4C10-8471-25EA187E2F98Q34254575-86BD1C33-4FED-4083-B272-607E122418AEQ34273065-FA532AC9-6A91-4A82-9AC9-0725572BC558Q35102897-A5B0252B-5D5F-4ACC-A384-8F20A7FBB8B2Q35242410-7A0963D0-79E2-46B7-8886-7373712EA81DQ35443377-92B16741-D653-4A58-B0F3-7E1CCD1DAD04Q35832606-F2DB8CA8-C182-4B0F-A921-2A1AFD3B8469Q35832849-323BDC2E-BED7-439C-B639-72F133A8E2B5Q35834240-CBE9BE8E-E465-4293-BB47-142AFBB594DBQ35917824-BFBE140E-6D1E-4335-8406-904D688F58EEQ36235391-7106EF62-F54D-416F-88C6-CEA73CB92436Q36410134-304AC256-6B46-4A36-8ED1-B58968871E8FQ36476991-E5EC1E5D-ED30-49B0-A9B3-7D55EB7BB124Q36554296-B22C6CB6-482C-4218-8E81-12167D4F7685Q36950042-4D831DED-FFE4-494B-9051-1BAD193B681CQ37092735-0507BE98-56C1-4188-8EF0-AECA2622999CQ37372948-B145C98F-EB93-4838-831A-31B79EE88B61Q37452311-C3343B3B-EAB8-41B5-8958-9B161825E527Q37671455-25AD3F11-977C-4EE6-989F-A3454E6668C1Q37905130-4BC31155-F1B1-4A7D-9CD4-0DC1FE912109Q37956513-AD0721DB-84D7-4DCA-AAAD-B0CFA8CB1AA0Q38050513-013C4957-0FD4-4433-8240-ED0AB92932FAQ39233501-2D459C49-5029-4E05-9D0C-31111F30DE9FQ40672836-B1573A4B-EDC3-4D94-9BE4-F50463405623Q41966102-DE024675-D889-4C81-ABA9-AE4603B959B2Q42003949-13AD11EC-0F32-4592-90CC-21C58F13916EQ42755469-DCE3C4BB-9B75-486B-8294-DDC94BD5629BQ45927193-D69FEE5E-ABE4-45C7-A65A-F4C656E2C537Q48946243-E9427DB4-D713-476F-8878-F748A011E950Q57526641-15268AFE-DEF2-4555-A91B-30A895B722A5Q58287534-0B097066-87E4-4112-9F1D-74E98B9B6952
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Amyloid precursor protein in aged nonhuman primates.
@en
Amyloid precursor protein in aged nonhuman primates.
@nl
type
label
Amyloid precursor protein in aged nonhuman primates.
@en
Amyloid precursor protein in aged nonhuman primates.
@nl
prefLabel
Amyloid precursor protein in aged nonhuman primates.
@en
Amyloid precursor protein in aged nonhuman primates.
@nl
P2093
P2860
P356
P1476
Amyloid precursor protein in aged nonhuman primates.
@en
P2093
A Weidemann
K Beyreuther
L J Martin
S S Sisodia
T L Dellovade
P2860
P304
P356
10.1073/PNAS.88.4.1461
P407
P577
1991-02-01T00:00:00Z